Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis.
Jessica FrauGiancarlo CogheLorena LoreficeGiuseppe FenuLuigina MusuEleonora CoccoPublished in: Journal of neurology (2019)
We confirmed the clinical and MRI efficacy of alemtuzumab in the clinical setting and the frequency of infusion-related reactions. Compared with that in clinical trials, higher number of patients developed pneumonitis during infusion.
Keyphrases
- clinical trial
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- peritoneal dialysis
- randomized controlled trial
- computed tomography
- rheumatoid arthritis
- contrast enhanced
- magnetic resonance
- interstitial lung disease
- patient reported
- diffusion weighted imaging